Sensus Healthcare, Inc SRTS
$3.12
-1.27%
at last close
Market Cap$52.02 million
P/E Ratio—
Div Yield—
Volume13.7K
52-Week Range
$2.66$5.50
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $5.00 (+60.3% upside)
Key Stats
- Today's Range
- $3.12 – $3.16
- 50-Day Range
- $2.80 – $3.72
- 52-Week Range
- $2.66 – $5.50
- Volume
- 14K shs
- Average Volume
- 37K shs
- Market Cap
- $52.02 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.41
- Price / Sales
- 2.97
Short Interest
- Short Interest
- 0.30%
- Days to Cover
- 23.88
Financials (TTM)
- Revenue
- $17.51 million
- Net Income
- $-15,485,000
- Net Margin
- -88.45%
- Return on Equity
- -42.01%
- Debt-to-Equity
- —
About Sensus Healthcare, Inc
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Related Stocks
Compare head-to-head: SRTS vs SYK·SRTS vs BSX·SRTS vs RMD·SRTS vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.